Methylphenidate (MP) and amphetamine (AMPH) are the most frequently prescribed medications for the treatment of attention-deficit/hyperactivity disorder (ADHD). Both drugs are believed to derive their therapeutic benefit by virtue of their dopamine (DA)-enhancing effects, yet an explanation for the observation that some patients with ADHD respond well to one medication but not to the other remains elusive. The dopaminergic effects of MP and AMPH are also thought to underlie their reinforcing properties and ultimately their abuse. Polymorphisms in the human gene that codes for the DA D4 receptor (D4R) have been repeatedly associated with ADHD and may correlate with the therapeutic as well as the reinforcing effects of responses to these psychostimulant medications. Conditioned place preference (CPP) for MP, AMPH and cocaine were evaluated in wild-type (WT) mice and their genetically engineered littermates, congenic on the C57Bl/6J background, that completely lack D4Rs (knockout or KO). In addition, the locomotor activity in these mice during the conditioning phase of CPP was tested in the CPP chambers. D4 receptor KO and WT mice showed CPP and increased locomotor activity in response to each of the three psychostimulants tested. D4R differentially modulates the CPP responses to MP, AMPH and cocaine. While the D4R genotype affected CPP responses to MP (high dose only) and AMPH (low dose only) it had no effects on cocaine. Inasmuch as CPP is considered an indicator of sensitivity to reinforcing responses to drugs these data suggest a significant but limited role of D4Rs in modulating conditioning responses to MP and AMPH. In the locomotor test, D4 receptor KO mice displayed attenuated increases in AMPH-induced locomotor activity whereas responses to cocaine and MP did not differ. These results suggest distinct mechanisms for D4 receptor modulation of the reinforcing (perhaps via attenuating dopaminergic signalling) and locomotor properties of these stimulant drugs. Thus, individuals with D4 receptor polymorphisms might show enhanced reinforcing responses to MP and AMPH and attenuated locomotor response to AMPH.
Ariano, MA, Wang, J., Noblett, KL, Larson, ER, Sibley, DR ( 1997) Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res752: 26-34.
2.
Aujla, H., Beninger, RJ ( 2005) The dopamine D(3) receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats. Behav Pharmacol16: 181-186.
3.
Avale, ME, Falzone, TL, Gelman, DM, Low, MJ, Grandy, DK, Rubinstein, M. ( 2004) The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatry9: 718-726.
4.
Belzung, C., Barreau, S. ( 2000) Differences in drug-induced place conditioning between BALB/c and C57Bl/6 mice. Pharmacol Biochem Behav65: 419-423.
5.
Bernards, CM ( 1996) Centrally mediated hemodynamic effects of cocaine in rabbits: the role of local anesthetic actions and biogenic amine re-uptake blockage . Eur J Pharmacol307: 33-39.
6.
Borycz, J., Zapata, A., Quiroz, C., Volkow, ND, Ferre, S. ( 2008) 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. Neuropsychopharmacology33: 619-626.
7.
Brabant, C., Charlier, Y., Quertemont, E., Tirelli, E. ( 2005a) The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice. Behav Brain Res160: 161-168.
8.
Brabant, C., Quertemont, E., Tirelli, E. ( 2005b) Evidence that the relations between novelty-induced activity, locomotor stimulation and place preference induced by cocaine qualitatively depend upon the dose: a multiple regression analysis in inbred C57BL/6J mice . Behav Brain Res158: 201-210.
9.
Castellanos, FX, Tannock, R. ( 2002) Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci3: 617-628.
10.
Cervo, L., Burbassi, S., Colovic, M., Caccia, S. ( 2005) Selective antagonist at D3 receptors, but not non-selective partial agonists, influences the expression of cocaine-induced conditioned place preference in free-feeding rats. Pharmacol Biochem Behav82: 727-734.
11.
Cunningham, CL, Howard, MA, Gill, SJ, Rubinstein, M., Low, MJ, Grandy, DK ( 2000) Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. Pharmacol Biochem Behav67: 693-699.
12.
Czermak, C., Lehofer, M., Liebmann, PM, Traynor, J. ( 2006) [35S] GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine. Eur J Pharmacol531: 20-24.
13.
de Wit, H., Uhlenhuth, EH, Johanson, CE ( 1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend16: 341-360.
14.
de Wit, H., Uhlenhuth, EH, Johanson, CE ( 1987) The reinforcing properties of amphetamine in overweight subjects and subjects with depression. Clin Pharmacol Ther42: 127-136.
15.
DiMaio, S., Grizenko, N., Joober, R. ( 2003) Dopamine genes and attention-deficit hyperactivity disorder: a review. J Psychiatry Neurosci28: 27-38.
16.
Ding, YC, Chi, HC, Grady, DL, Morishima, A., Kidd, JR, Kidd, KK, et al. (2002) Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci U S A99: 309-314.
17.
Du, C., Yu, M., Volkow, ND, Koretsky, AP, Fowler, JS, Benveniste, H. ( 2006) Cocaine increases the intracellular calcium concentration in brain independently of its cerebrovascular effects. J Neurosci26: 11522-11531.
Falzone, TL, Gelman, DM, Young, JI, Grandy, DK, Low, MJ, Rubinstein, M. ( 2002) Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. Eur J Neurosci15: 158-164.
Filip, M., Frankowska, M., Zaniewska, M., Golda, A., Przegalinski, E. ( 2005) The serotonergic system and its role in cocaine addiction . Pharmacol Rep57: 685-700.
22.
Gatley, SJ, Meehan, SM, Chen, R., Pan, DF, Schechter, MD, Dewey, SL ( 1996) Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci58: PL345-PL352.
23.
Gatley, SJ, Volkow, ND, Gifford, AN, Fowler, JS, Dewey, SL, Ding, YS, et al. (1999) Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology (Berl)146: 93-100.
24.
Gilbert, JG, Newman, AH, Gardner, EL, Ashby Jr, CR, Heidbreder, CA, Pak, AC, et al. (2005) Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse57: 17-28.
25.
Gordon, SM, Tulak, F., Troncale, J. ( 2004) Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence. J Addict Dis23: 31-40.
26.
Grady, DL, Chi, HC, Ding, YC, Smith, M., Wang, E., Schuck, S., et al. (2003) High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder . Mol Psychiatry8: 536-545.
27.
Hall, FS, Li, XF, Sora, I., Xu, F., Caron, M., Lesch, KP, et al. (2002) Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions . Neuroscience115: 153-161.
28.
Hall, FS, Sora, I., Drgonova, J., Li, XF, Goeb, M., Uhl, GR ( 2004) Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci1025: 47-56.
29.
Han, DD, Gu, HH ( 2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol6: 2210-2216.
Hoebel, BG, Monaco, AP, Hernandez, L., Aulisi, EF, Stanley, BG, Lenard, L. ( 1983) Self-injection of amphetamine directly into the brain . Psychopharmacology (Berl)81: 158-163.
32.
Itzhak, Y., Martin, JL ( 2002) Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants . Neuropsychopharmacology26: 130-134.
33.
Katz, JL, Chausmer, AL, Elmer, GI, Rubinstein, M., Low, MJ, Grandy, DK ( 2003) Cocaine-induced locomotor activity and cocaine discrimination in dopamine D4 receptor mutant mice. Psychopharmacology (Berl)170: 108-114.
34.
Kruzich, PJ, Suchland, KL, Grandy, DK ( 2004) Dopamine D4 receptor-deficient mice, congenic on the C57BL/6J background, are hypersensitive to amphetamine. Synapse53: 131-139.
35.
Kuczenski, R., Segal, DS ( 1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem68: 2032-2037.
36.
LaHoste, GJ, Swanson, JM, Wigal, SB, Glabe, C., Wigal, T., King, N., et al. (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry1: 121-124.
37.
Lanau, F., Zenner, MT, Civelli, O., Hartman, DS ( 1997) Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem68: 804-812.
38.
Le Foll, B., Sokoloff, P., Stark, H., Goldberg, SR ( 2005) Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminativestimulus or antidepressant-like effects. Neuropsychopharmacology30: 720-730.
39.
Li, D., Sham, PC, Owen, MJ, He, L. ( 2006) Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) . Hum Mol Genet15: 2276-2284.
40.
Martin-Iverson, MT, Ortmann, R., Fibiger, HC ( 1985) Place preference conditioning with methylphenidate and nomifensine. Brain Res332: 59-67.
41.
McGough, J., McCracken, J., Swanson, J., Riddle, M., Kollins, S., Greenhill, L., et al. (2006) Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry45: 1314-1322.
42.
Meador-Woodruff, JH, Grandy, DK, Van Tol, HH, Damask, SP, Little, KY, Civelli, O., et al. (1994) Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology10: 239-248.
43.
Meririnne, E., Kankaanpaa, A., Seppala, T. ( 2001) Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Therv298: 539-550.
44.
Missale, C., Nash, SR, Robinson, SW, Jaber, M., Caron, MG ( 1998) Dopamine receptors: from structure to function . Physiol Rev78: 189-225.
45.
Mithani, S., Martin-Iverson, MT, Phillips, AG, Fibiger, HC ( 1986) The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity . Psychopharmacology (Berl)90: 247-252.
46.
Mrzljak, L., Bergson, C., Pappy, M., Huff, R., Levenson, R., Goldman-Rakic, PS ( 1996) Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature381: 245-248.
47.
Newman-Tancredi, A., Audinot-Bouchez, V., Gobert, A., Millan, MJ ( 1997) Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Eur J Pharmacol319: 379-383.
48.
Nielsen, JA, Duda, NJ, Mokler, DJ, Moore, KE ( 1984) Self-administration of central stimulants by rats: a comparison of the effects of d-amphetamine, methylphenidate and McNeil 4612 . Pharmacol Biochem Behav20: 227-232.
49.
Parran Jr., TV, Jasinski, DR ( 1991) Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch Intern Med151: 781-783.
Pum, M., Carey, RJ, Huston, JP, Muller, CP ( 2007) Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats. Psychopharmacology (Berl)193: 375-390.
52.
Rezayof, A., Zarrindast, MR, Sahraei, H., Haeri-Rohani, AH ( 2002) Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol Biochem Behav74: 187-197.
53.
Ricci, A., Bronzetti, E., Fedele, F., Ferrante, F., Zaccheo, D., Amenta, F. ( 1998) Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart. J Auton Pharmacol18: 115-121.
54.
Robbins, TW, Everitt, BJ ( 1996) Neurobehavioural mechanisms of reward and motivation . Curr Opin Neurobiol6: 228-236.
55.
Rubinstein, M., Phillips, TJ, Bunzow, JR, Falzone, TL, Dziewczapolski, G., Zhang, G., et al. (1997) Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell90: 991-1001.
56.
Rush, CR, Essman, WD, Simpson, CA, Baker, RW ( 2001) Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol21: 273-286.
57.
Shimozato, KW, Watanabe, S. ( 2003) Concurrent evaluation of locomotor response to nevelty and propensity toward cocaine conditioned place preference in mice . J Neurosci Methods128: 103-110.
58.
Sulzer, D., Sonders, MS, Poulsen, NW, Galli, A. ( 2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol75: 406-433.
59.
Swanson, JM, Sunohara, GA, Kennedy, JL, Regino, R., Fineberg, E., Wigal, T., et al. (1998) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry3: 38-41.
60.
Viggiano, D., Ruocco, LA, Sadile, AG ( 2003) Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder. Neurosci Biobehav Rev27: 623-637.
61.
Volkow, ND ( 2006) Stimulant medications: how to minimize their reinforcing effects. Am J Psychiatry163: 359-361.
62.
Volkow, ND, Wang, G., Fowler, JS, Logan, J., Gerasimov, M., Maynard, L., et al. (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci21: RC121 (1-5).
63.
Volkow, ND, Wang, GJ, Fowler, JS, Telang, F., Maynard, L., Logan, J., et al. (2004) Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain . Am J Psychiatry161: 1173-1180.
64.
Wang, E., Ding, YC, Flodman, P., Kidd, JR, Kidd, KK, Grady, DL, et al. (2004) The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am J Hum Genet74: 931-944.
65.
Wedemeyer, C., Goutman, JD, Avale, ME, Franchini, LF, Rubinstein, M., Calvo, DJ ( 2007) Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes . Eur J Pharmacol562: 165-173.
66.
Williard, RL, Middaugh, LD, Zhu, HJ, Patrick, KS ( 2007) Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity . Behav Pharmacol18: 39-51.
67.
Wise, RA, Hoffman, DC ( 1992) Localization of drug reward mechanisms by intracranial injections. Synapse10: 247-263.
68.
Yokel, RA, Wise, RA ( 1978) Amphetamine- type reinforcement by dopaminergic agonists in the rat. Psychopharmacology (Berl)58: 289-296.
69.
Zhang, K., Tarazi, FI, Davids, E., Baldessarini, RJ ( 2002) Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology26: 625-633.
